Premium domains across precision medicine verticals — oncology and liquid biopsy, pharma and therapeutics, medical imaging AI, and cardiology / structural heart.
Precision oncology, structural heart programs, and AI-enabled imaging are some of the highest-margin specialties in modern medicine. Names like ctdnahealth.com (circulating tumor DNA) and mitralreplacement.com (TAVR/TMVR) are category-defining anchors that biotech and device founders cannot replicate.
A focused selection of exact-match and authority .com names across oncology and cancer diagnostics, pharma and therapeutics, medical imaging AI, and cardiology / structural heart — the four specialties driving precision medicine investment in 2026.
Every domain is available via Sedo — secure escrow, no intermediaries. Click any name to view it on Sedo.
Premium domain for non-opioid pain management — novel analgesics, pain therapeutics, and addiction-free treatment platforms.
High-value domain for machine vision in healthcare — medical imaging AI, pathology automation, and surgical guidance.
Exact-match domain for mitral valve replacement — transcatheter procedures, structural heart innovation, and cardiac surgery.
Photon-counting CT technology domain — next-generation spectral imaging, multi-energy CT, and advanced radiology platforms.
Circulating tumor DNA domain for liquid biopsy, cancer screening, minimal residual disease monitoring, and precision oncology.
PET/MRI hybrid imaging technology domain — multimodal imaging, oncology diagnostics, and neuroimaging platforms.
ctDNA monitoring domain for cancer recurrence surveillance, treatment response tracking, and liquid biopsy services.
Bispecific antibody oncology domain — dual-target immunotherapy, T-cell engagers, and cancer treatment innovation.
Cancer patient-reported outcomes domain — oncology PROMs, survivorship tracking, and quality of life measurement.
Minimal residual disease platform domain — MRD testing, cancer monitoring, and molecular diagnostics infrastructure.
Transcatheter mitral valve repair/replacement domain — minimally invasive cardiac intervention and structural heart devices.
liquidmrd.com — premium .com fusing liquid biopsy and MRD (minimal residual disease), the two most valuable categories in precision oncology 2026. Natera Signatera, Guardant Reveal, Exact Sciences Oncodetect, NeoGenomics RaDaR all scaling in this space. Ideal for ctDNA MRD diagnostic startups, AI-first cancer surveillance platforms, liquid-biopsy labs, and pharma companion diagnostics. Exact-match, category-authority, investor-ready.
MRD cancer test domain for minimal residual disease testing, precision oncology diagnostics, and cancer monitoring.
Nav1.8 pain domain — sodium channel blockers, non-opioid analgesics, and targeted pain therapeutics.
Specialty TLD for oncology, immuno-oncology, precision oncology, and tumor research platforms.
GLP-1 obesity treatment domain — incretin therapy, weight management programs, and metabolic care platforms.
Nav1.8 blocker domain for sodium channel pain therapeutics, non-addictive analgesic development.
Professional B2B .com for molecular surveillance platforms — NCCN and ASCO-adopted terminology for longitudinal ctDNA and MRD monitoring in oncology.
Domain for cancer recurrence monitoring and ctDNA surveillance — fits precision oncology startups and oncology AI products building longitudinal recurrence-detection workflows.
MRD-negative status domain — oncology reporting, remission communication, and precision cancer care.
Premium domain for Advanced Therapy Medicinal Product (ATMP) hubs, consortia, and centres of excellence. EU Life Sciences Roadmap €10B+ investment makes this a category-defining name for European biotech clusters, CDMOs, and ATMP orchestration platforms.
Descriptive premium .com for metabolic health data platforms. Strong fit for GLP-1 real-world data companies, pharma analytics vendors, and metabolic research consortia.
PET/CT imaging technology domain for nuclear medicine, oncology staging, and molecular imaging platforms.
Specialty TLD for medical imaging, radiology AI, MRI, and CT diagnostic platforms.
Targeted domain for GLP-1 medication adherence — a multi-billion-dollar pharma problem. With oral incretins driving the fastest-growing drug category of the decade, adherence platforms are a core investment area for pharma, PBMs, and digital therapeutics.
Specialty TLD for radiology, teleradiology, radiology AI, and PACS imaging platforms.
Specialty TLD for cardiology, cardiac care, electrophysiology, and cardiovascular AI platforms.
Cancer care technology for oncology platforms, treatment coordination, and survivorship programs.
High-density diffuse optical tomography domain — fNIRS brain imaging, non-invasive neuroimaging technology.
Online brand for MRD testing education, oncology outreach, and diagnostic lead generation.
Pain care technology domain for chronic pain management, multidisciplinary treatment, and digital pain therapeutics.
Online brand for MRD-negative education, oncology communication, and clinical information.
Vascular health technology for cardiovascular screening, vein treatment, and circulatory health monitoring.
Serious inquiries only. Reach out for portfolio questions, bundle negotiations, or custom category packages.
Email sales sales@mednamehub.com